US patent

Anixa Biosciences Secures US Patent for Breakthrough Breast Cancer Vaccine Technology

by

Anixa Biosciences, Inc. (NASDAQ: ANIX) has received a new U.S. patent for its innovative breast cancer vaccine technology. The United States Patent and Trademark Office (USPTO) will officially issue Patent No. 12,472,205 on November 18, 2025, marking a major step forward for the company’s preventive cancer program.

The newly granted patent protects methods that trigger an immune response to the protein α-lactalbumin. This protein is normally present in breast tissue during lactation but is also found in certain types of breast cancer. By targeting α-lactalbumin, the vaccine aims to train the immune system to recognize and destroy emerging cancer cells before they form tumors.

The breast cancer vaccine was developed by researchers at the Cleveland Clinic, led by Dr. Vincent Tuohy and Dr. Justin Johnson. Anixa holds an exclusive worldwide license to this technology from the Cleveland Clinic. The company stated that the new patent extends its intellectual property protection for the vaccine into the mid-2040s, strengthening its long-term development and commercialization strategy.

According to Anixa’s CEO, the patent marks a key milestone in the company’s mission to create a first-of-its-kind preventive breast cancer vaccine. He emphasized that strong patent protection provides the foundation for advancing the vaccine through future clinical trials and regulatory stages.

Anixa’s breast cancer vaccine remains investigational and is currently in the clinical testing phase. Early-stage trials have focused on evaluating its safety and immune response in healthy volunteers and breast cancer survivors. The company plans to expand studies to assess the vaccine’s ability to prevent the onset of cancer in high-risk populations.

If successful, this vaccine could become a historic medical advancement, offering women a proactive way to prevent one of the world’s most common cancers.

Indian-Origin Autistic Teen and Father File US Patent for Inclusive AI-Powered Invention

by

In a compelling story of innovation, inclusion, and perseverance, a 15-year-old Indian-origin autistic teenager from Dubai has co-filed a U.S. patent for a revolutionary AI-powered invention aimed at addressing global challenges through inclusive design. The young innovator, Zayne Sodawaterwala, teamed up with his father, Merzi Sodawaterwala, to create what they call a “universal human invention” that combines cutting-edge technology with a vision of accessibility and sustainability.

AI-Driven Solution for All Abilities

Filed with the United States Patent and Trademark Office (USPTO) on June 11, 2025, the invention brings together intelligent mobility solutions, regenerative wearable devices, multi-sensory adaptive learning tools, immersive experiences, and eco-conscious design principles. The integrated system is tailored to support people across a wide range of cognitive and physical abilities, especially the neurodiverse and underserved populations.

According to Merzi Sodawaterwala, the invention is “a generational blueprint for an equitable, connected and resilient world,” with potential applications in education, health, urban planning, and social innovation.

Record-Breaking Teen Redefines Autism

Zayne Sodawaterwala, diagnosed as autistic, is no stranger to remarkable achievements. Earlier this year, he broke the Guinness World Record for the fastest 10 km inline skate by a teenager with a time of 40 minutes and 4 seconds, achieved on Dubai’s Al Qudra Track. He followed that up with a 42.55 km marathon skate at the Yas Marina F1 Circuit in Abu Dhabi, completed in just over four hours.

These feats not only earned him recognition from the Special Olympics UAE but also made him the youngest and first neurodivergent world record holder in this category. His determination, self-discipline, and emotional control defy traditional stereotypes about autism.

“Zayne’s journey is an example of how neurodivergent individuals are capable of remarkable self-led transformation,” said his father. “He’s living proof that autism can be a source of strength, not limitation.”

Global Relevance and Societal Impact

The invention, currently under review by the USPTO, is envisioned as a versatile platform capable of improving quality of life across sectors. With AI at its core, the device is designed to personalize experiences for users while supporting inclusive, community-driven growth. It emphasizes real-time feedback, sustainability, and emotional engagement—principles considered essential for next-generation smart environments.

The Sodawaterwalas believe that their innovation can play a pivotal role in creating accessible educational tools, enhancing mental health care, designing future-ready cities, and even addressing climate challenges.

A Vision Beyond Innovation

This patent application is more than a technological achievement; it represents a statement about human potential, inclusion, and the power of family-driven creativity. It challenges global norms around ability, equity, and innovation, setting a powerful precedent for neurodiverse leadership in STEM.

As the world awaits the USPTO’s decision, one thing is clear: the Sodawaterwalas have sparked a global conversation around the role of neurodiversity in shaping a smarter, more compassionate future.